- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Acrobiosystems Co Ltd (301080)
The Acrobiosystems share price today is 45.02, view SZ 301080 stock exchange data. Track the latest Acrobiosystems share price with real-time updates on 301080 stock performance including market cap, day range, 52-week range and dividend yield. Access 301080 charts, earnings dates and analyst estimates to support your investment decisions.
Shenzhen
Currency in CNY
45.02
+0.45(+1.01%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.41
45.60
52 wk Range
35.87
71.49
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.4145.60
52 wk Range
35.8771.49
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
301080 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
72.71
Upside
+61.50%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 72.71
(+61.50% Upside)
Earnings
Latest Release
21-04-2026
EPS / Forecast
0.28 / 0.45
Revenue / Forecast
236M / --
Compare 301080 to Peers and Sector
Metrics to compare | 301080 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship301080PeersSector | |
|---|---|---|---|---|
P/E Ratio | 43.5x | 48.3x | −0.4x | |
PEG Ratio | 1.34 | −0.93 | 0.00 | |
Price/Book | 2.8x | 2.0x | 2.6x | |
Price / LTM Sales | 8.4x | 6.3x | 3.0x | |
Upside (Analyst Target) | 64.7% | 42.8% | 55.7% | |
Fair Value Upside | Unlock | 20.4% | 8.1% | Unlock |
Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions. It provides kits, scientific services, and other related products under the Resilient Supply, CytoPak, SAFENSURE, FLAG, Star Staining, Aneuro, ComboX, and GENPower brands. The company also offers cell therapies, gene therapies, therapeutic antibodies, antibody-drug conjugates, core reagents for infectious disease research, and solutions for metabolic and autoimmune disease drug development. In addition, it provides custom reagent, assay development, and analytical services. Further, the company is involved in general business, sales and technical services of biological products, manufacture and sells medical devices, research and development of biological reagent products, business information consulting and conference, and company testing service businesses. The company’s products are used in drug screening and optimization for diseases such as cancer, autoimmune diseases, cardiovascular diseases, and infectious diseases; diagnostic reagent development and optimization; preclinical and clinical trials; and drug manufacturing processes and process control. Acrobiosystems Co.,Ltd. was founded in 2010 and is based in Beijing, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Acrobiosystems (301080) Share Price Today?
The Acrobiosystems share price today is 45.02.
What is the current Acrobiosystems (301080) share price and day range?
As of 25-06-2026, the Acrobiosystems share price is 45.02, with a previous close of 44.57. The share price has ranged from 41.41 to 45.60 today, while the 52-week range spans from 35.87 to 71.49.
What Is the Acrobiosystems Market Cap?
As of today, Acrobiosystems market cap is 7.45B.
Does Acrobiosystems Pay Dividends? What's The Current Dividend Yield?
The Acrobiosystems dividend yield is 1.45%.
What Is the Acrobiosystems (301080) Share Price Target?
The average 12-month share price target for Acrobiosystems is 72.71, with a high estimate of 80 and a low estimate of 64.05. 6 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +61.50% Upside potential.
What Is Acrobiosystems's Earnings Per Share (TTM)?
The Acrobiosystems EPS (TTM) is 1.04.
When Is the Next Acrobiosystems Earnings Date?
Acrobiosystems will release its next earnings report on 01-09-2026.
From a Technical Analysis Perspective, Is 301080 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Acrobiosystems Trade On?
Acrobiosystems is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for Acrobiosystems?
The stock symbol for Acrobiosystems is "301080."
How Many Times Has Acrobiosystems Stock Split?
Acrobiosystems has split 2 times.
How Many Employees Does Acrobiosystems Have?
Acrobiosystems has 926 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.